Fosnetupitant Chloride Hydrochloride; Palonosetron Hydrochloride Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as HELSINN HLTHCARE. It is marketed under 1 brand name, including AKYNZEO. Available in 2 different strengths, such as EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL, EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML), and administered through 2 routes including POWDER;INTRAVENOUS, SOLUTION;INTRAVENOUS.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"45557","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"0aa6b3f3bcd9410fabee","publication_number":"US9186357B2","cleaned_patent_number":"9186357","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-18","publication_date":"2015-11-17","legal_status":"Granted"} US9186357B2 17 Nov, 2015 Granted 18 Nov, 2030
{"application_id":"45559","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"0aa6b3f3bcd9410fabee","publication_number":"US10828297B2","cleaned_patent_number":"10828297","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-17","publication_date":"2020-11-10","legal_status":"Granted"} US10828297B2 10 Nov, 2020 Granted 17 Dec, 2030
{"application_id":"66292","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"b1991e14fe7744198ed2","publication_number":"US11312698B2","cleaned_patent_number":"11312698","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-23","publication_date":"2022-04-26","legal_status":"Patented case"} US11312698B2 Molecular Formulation 26 Apr, 2022 Patented case 23 May, 2032
{"application_id":"66233","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"b1991e14fe7744198ed2","publication_number":"US10208073B2","cleaned_patent_number":"10208073","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-23","publication_date":"2019-02-19","legal_status":"Granted"} US10208073B2 19 Feb, 2019 Granted 23 May, 2032
{"application_id":"66291","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"b1991e14fe7744198ed2","publication_number":"US10717721B2","cleaned_patent_number":"10717721","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-23","publication_date":"2020-07-21","legal_status":"Granted"} US10717721B2 Molecular 21 Jul, 2020 Granted 23 May, 2032
{"application_id":"66288","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"b1991e14fe7744198ed2","publication_number":"US8895586B2","cleaned_patent_number":"8895586","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-23","publication_date":"2014-11-25","legal_status":"Granted"} US8895586B2 25 Nov, 2014 Granted 23 May, 2032
{"application_id":"66289","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"b1991e14fe7744198ed2","publication_number":"US9403772B2","cleaned_patent_number":"9403772","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-23","publication_date":"2016-08-02","legal_status":"Granted"} US9403772B2 Molecular 02 Aug, 2016 Granted 23 May, 2032
{"application_id":"66290","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"b1991e14fe7744198ed2","publication_number":"US9908907B2","cleaned_patent_number":"9908907","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-23","publication_date":"2018-03-06","legal_status":"Granted"} US9908907B2 Molecular Formulation 06 Mar, 2018 Granted 23 May, 2032
{"application_id":"66287","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"b1991e14fe7744198ed2","publication_number":"US8426450B1","cleaned_patent_number":"8426450","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-05-23","publication_date":"2013-04-23","legal_status":"Patented case"} US8426450B2 Molecular Formulation 23 Apr, 2013 Patented case 23 May, 2032
{"application_id":"66330","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"dc86d787d12542f198e3","publication_number":"US11529362B2","cleaned_patent_number":"11529362","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-06-02","publication_date":"2022-12-20","legal_status":"Granted"} US11529362B2 Formulation 20 Dec, 2022 Granted 02 Jun, 2037
{"application_id":"164425","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"dc86d787d12542f198e3","publication_number":"US12208109B2","cleaned_patent_number":"12208109","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-06-02","publication_date":"2025-01-28","legal_status":"Granted"} US12208109B2 Formulation 28 Jan, 2025 Granted 02 Jun, 2037
{"application_id":"66298","ingredient":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE","trade_name":"AKYNZEO","family_id":"dc86d787d12542f198e3","publication_number":"US10624911B2","cleaned_patent_number":"10624911","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-06-02","publication_date":"2020-04-21","legal_status":"Granted"} US10624911B2 Formulation 21 Apr, 2020 Granted 02 Jun, 2037

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Fosnetupitant Chloride Hydrochloride; Palonosetron Hydrochloride

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.